AdvaMed Statement on the Klomp Nomination
- Coverage & Payment
- Diagnostics
- Digital Health
- Government & Legislative Affairs
- Health Access
- Regulatory Affairs
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the largest trade association representing medtech innovators, posted his statement on LinkedIn regarding the nomination of Chris Klomp as deputy secretary of the Department of Health and Human Services:
https://www.linkedin.com/feed/update/urn:li:share:7476339373047951360/
Related Reading
Event / AdvaMed Advancements / Business Development / Government & Legislative Affairs / Regulatory Affairs / Small Business
AdvaMed® Medtech Showcase
September 16, 2026
5:00 PM – 7:00 PM
Experience the future of health care at the 2026 Medtech Showcase and Reception on Capitol Hill. Join AdvaMed® on September 16 for an interactive event featuring more than 25 medtech companies demonstrating breakthrough technologies that are transforming patient care. See innovative medical devices firsthand, connect with industry leaders and policymakers, and discover how medtech innovation is improving and saving lives.
News / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Strongly Supports Draft MDUFA VI Agreement at FDA Public Meeting
August 5, 2026
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today expressed strong support for the draft Medical Device User Fee Amendments (MDUFA) VI agreement at an FDA public hearing.
Event / Health Access
Investing in Women’s Health Products and Companies
September 24, 2026
1:00 PM – 2:00 PM
Examine the evolving investment landscape, share lessons learned, and discuss strategies that help women’s health companies attract investment and drive growth.
Event / Regulatory Affairs
From Launch to Exit: Leveraging IP to Build and Protect Enterprise Value
October 6, 2026
1:00 PM – 2:00 PM
Join Cooley LLP as they explore how to evaluate and strengthen your IP position, prepare for competitive challenges, and avoid common pitfalls that can undermine value during due diligence and transactions.
Resource / Coverage & Payment / Government & Legislative Affairs / Health Access
Gateways to Health: How Medtech Is Improving Care While Lowering Healthcare Costs
July 31, 2026
Read Gateways to Health, a special publication exploring how medical technology improves patient care, expands access, and lowers healthcare costs.
Event / Global & Trade / Regulatory Affairs
Entering the Japanese Medical Device Market: Regulatory Pathways, Consultation Opportunities, and Practical Insights
September 1, 2026 |
7:00 PM – 8:30 PM ET
September 2, 2026 |
8:00 AM – 9:30 AM JST
Learn how to enter Japan’s medtech market with insights on regulatory pathways, consultation services, and practical insights for U.S. medtech companies.
Blog / Artificial Intelligence (AI) / Diagnostics / Digital Health / Health Access
The Insight Series: AI & Digital Health
July 27, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. Our latest edition features Jacque Engle, Vice President of Marketing & Communication and Juli Goldstein, Vice President of Government Affairs & Market Access at Digital Diagnostics.
Resource / Digital Health
From Mechanical Precision to Software Intelligence: How Medtech can follow Automotive’s Digital Transformation Playbook
July 21, 2026
In From Mechanical Precision to Software Intelligence, Kearney explores how MedTech companies can learn from the automotive industry’s shift to software-defined platforms. The article examines how connected devices, AI-enabled services, cloud-based capabilities, and recurring software revenues can help medical technology manufacturers improve customer value, accelerate innovation, and remain competitive in an increasingly digital healthcare landscape.
Call to Action Heading…
Call to Action Description…